Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    22740508 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed GISSI-HF- Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic CHF
Condition: Heart Failure
Interventions: Drug: n-3 PUFA;   Drug: Rosuvastatin;   Drug: Placebo
2 Completed Crestor Versus Placebo in Subjects With Heart Failure
Condition: Heart Failure
Intervention: Drug: CRESTOR

Indicates status has not been verified in more than two years